Open Access

[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway

  • Authors:
    • Juntao Yao
    • Tao Xu
    • Tao Tian
    • Xiao Fu
    • Wenjuan Wang
    • Suoni Li
    • Tingting Shi
    • Aili Suo
    • Zhiping Ruan
    • Hui Guo
    • Yu Yao
  • View Affiliations

  • Published online on: May 13, 2024     https://doi.org/10.3892/or.2024.8748
  • Article Number: 89
  • Copyright : © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2024
Volume 52 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yao J, Xu T, Tian T, Fu X, Wang W, Li S, Shi T, Suo A, Ruan Z, Guo H, Guo H, et al: [Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway. Oncol Rep 52: 89, 2024.
APA
Yao, J., Xu, T., Tian, T., Fu, X., Wang, W., Li, S. ... Yao, Y. (2024). [Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway. Oncology Reports, 52, 89. https://doi.org/10.3892/or.2024.8748
MLA
Yao, J., Xu, T., Tian, T., Fu, X., Wang, W., Li, S., Shi, T., Suo, A., Ruan, Z., Guo, H., Yao, Y."[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway". Oncology Reports 52.1 (2024): 89.
Chicago
Yao, J., Xu, T., Tian, T., Fu, X., Wang, W., Li, S., Shi, T., Suo, A., Ruan, Z., Guo, H., Yao, Y."[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway". Oncology Reports 52, no. 1 (2024): 89. https://doi.org/10.3892/or.2024.8748